baber/WOPTO huggingface dataset:
Patent AU-5448794-A (AU)
Title: Selectively actuatable lighter
Inventor: MCDONOUGH JAMES M
IPC: F23Q2/28
Filed: 1993-10-22
Abstract: A selectively actuatable lighter device is disclosed which includes a body defining reservoir for containing a combustible gaseous medium such as butane, and having a valve arranged to be selectively actuated between a normally closed position and an open position which permits the exit of the gaseous medium. Such lighter can selectively produce sparks at a location proximate to the gaseous medium exit to ignite the gaseous medium. Such lighter device embodies a resiliently releasable latch means which normally prevents actuation of a valve actuator to the open position thereby preventing actuation of the valve. The latch means includes a latch which is selectively movable to a position out of interference with the valve actuator, so that the gaseous medium may be released and ignited by the sparks. The latch means is resiliently structured and mounted such that once the valve actuator is depressed and released, the latch returns to its closed or latched position to prevent actuation of the valve to the open position. To "re-use" the lighter, the latch must again be moved to an unlatched position so that the valve actuator can be opened for subsequent ignition of the gaseous medium.
Patent AU-5678090-A (AU)
Title: Manufacture of ferroalloys using a molten bath reactor
Inventor: BATTERHAM ROBIN JOHN
IPC: C21C5/28
Filed: 1990-05-30
Abstract: PCT No. PCT/AU90/00233 Sec. 371 Date Sep. 26, 1991 Sec. 102(e) Date Sep. 26, 1991 PCT Filed May 30, 1990 PCT Pub. No. WO90/15165 PCT Pub. Date Dec. 13, 1990.The specification discloses a process for producing a ferroalloy in a smelting vessel. A material containing an alloying metal is injected into a molten bath contained in the vessel. A flux, a carbonaceous material and an oxygen-containing gas are also injected into the vessel. A gas which may be the oxygen-containing gas is injected into the molten bath in order to stir it. The rates of injection of the various components are controlled to achieve control of the oxidizing and reducing environment within the vessel consistent with a rapid rate of injection. The material containing the alloying metal is either reduced and incorporated into the metal phase or oxidized and incorporated into the slag. Combustion gases above the molten bath are oxidized to provide further heat to the process. Alloyed metal or slag containing the alloying metal are recovered as product. The process is applicable to the production of ferroalloys such as ferrochromium, ferromanganese, ferronickel and ferrovanadium.
Patent AU-5758090-A (AU)
Title: Diaryl ether cyclic ethers
Inventor: BIRD THOMAS GEOFFREY COLERICK
IPC: A61P37/08
Filed: 1990-06-19
Abstract: The invention concerns a diaryl ether cyclic ether of the formula I, or a pharmaceutically-acceptable salt thereof, <CHEM>  wherein Ar<1> is optionally substituted phenyl or naphthyl;  X<1> is oxy, thio, sulphinyl or sulphonyl; Ar<2> is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms; R<1> and R<2> together form a group of the formula -A<2>-X<2>-A<3>- wherein each of A<2> and A<3> is (1-4C)alkylene and X<2> is oxy, thio, sulphinyl, sulphonyl or imino; and R<3> is (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl and substituted (1-4C)alkyl. The invention also concerns processes for the manufacture of a diaryl ether cyclic ether of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said cyclic ether. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
Patent AU-5811394-A (AU)
Title: Use of sterile mesomorphic phases in food products
Inventor: HEERTJE ISAAC
IPC: A23P30/40
Filed: 1993-12-09
Abstract: A process for the preparation of a sterile mesomorphic phase of surfactants, comprising the sequential steps of: (a) preparing a premix comprising surfactants and water at a temperature above the Krafft temperature of the surfactant; (b) sterilising the premix at a temperature above 115  DEG C; and (c) cooling the premix to below the Krafft temperature of the surfactants, said process also comprising (before, during or after step c) the aseptically filling into a suitable package.
Patent AU-5836600-A (AU)
Title: Chlamysin B antibacterial protein, gene encoding it and an expression system for it
Inventor: MYRNES BJORNAR
IPC: A61P31/04
Filed: 2000-06-23
Abstract: This invention relates to the novel antibacterial protein Chlamysin B, a novel protein gene encoding the Chlamysin B protein and an expression system using such gene in E. Coli.
Patent AU-5905790-A (AU)
Title: 2-acyl-1-(substituted aminomethyl-tetrahydroisoquinoline) derivatives
Inventor: VECCHIETTI VITTORIO
IPC: A61K31/472
Filed: 1990-07-16
Abstract: A compound, or a solvate or salt thereof, of formula (I): <CHEM>  in which: RCO is an acyl group in which the group R contains a substituted or unsubstituted carbocyclic aromatic or heterocyclic aromatic ring and R1 and R2 are independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-6 cycloalkyl or C4-12 cycloalkylalkyl groups or together form a C2-8 branched or linear polymethylene or C2-6 alkenylene group optionally substituted with a hetero-atom; R3 is hydrogen, C1-6 alkyl, preferably methyl or ethyl, or phenyl, or R3 together with R1 forms a -(CH2)3- or -(CH2)4-, group; R4 and R5 are identical and are hydrogen or C1-6 alkyl, or together form a C2-5 linear polymethylene group; R6 and R7 are identical and are hydrogen or C1-6 alkyl, or together form a C2-5 linear polymethylene group; or R5 and R6 are together -CH2- when each of R4 and R7 is hydrogen or C1-6 alkyl; with the proviso that R4, R5, R6 and R7 are not simultaneously hydrogen R8 and R9, which may be the same or different, are each hydrogen, C1-6 alkyl, -CH2OR10, halogen, hydroxy, C1-6 alkoxy, C1-6 alkoxycarbonyl, thiol, C1-6 alkylthio,   -O @R11, -NHCOR12, -NHSO2R13, -CH2SO2NR14R15, in which each of R10 to R15 is independently hydrogen, C1-6 alkyl, aryl or aralkyl, is useful for the treatment of pain, and or hyponatraemic disease states and/or cerebral ischaemia.
Patent AU-5972490-A (AU)
Title: (R-(R*R*))-2-(4-fluorohpenyl)-beta,delta-dihydroxy-5-(1- methylethyl-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1- heptanoic acid, its lactone form and salts thereof
Inventor: ROTH BRUCE DAVID
IPC: C07D405/06
Filed: 1990-07-23
Abstract: R-(R*,R*)­-2-(4-fluorophenyl)- beta , delta -dihydroxy-5-((1-methylethyl)-3-phenyl-4- (phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid or (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl-N,4-diphenyl-1- 2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl­-1H-pyrrole-3-carbo xamide; a process for their preparation and pharmaceutically acceptable salts thereof.
Patent AU-6033296-A (AU)
Title: Blood glucose monitoring system
Inventor: LEPPER JAMES M JR
IPC: A61B5/1455
Filed: 1996-06-04
Abstract: A blood glucose monitoring system includes a broadband light source and a specially fabricated optical filter for modulating optical radiation to be transmitted through a fleshy medium. Optical radiation which passes through the fleshy medium is detected by an optical detector which generates an electrical signal indicative of the intensity of the detected light. Digital signal processing is performed on the electrical signal to extract those optical characteristics of the electrical signal due to the optical characteristics of the filter and constituents of the fleshy May 1, 1995 medium other than blood glucose concentration. The monitoring system employs a unique "double-log" transformation to minimize errors due to indeterminate path length variations of the optical radiation through the fleshy medium. The monitoring system further employs specialized signal processing to avoid inaccuracies due to the previously unidentified solvent effect which arises when glucose is dissolved into water.
Patent AU-6066886-A (AU)
Title: Multi-focal spectacle lens having at least one progressive surface
Inventor: FURTER GERHARD
IPC: G02C7/02
Filed: 1986-07-29
Abstract: The invention contemplates a multi-focal spectacle lens having two progressive zones which are spatially separated from each other and which provide smooth transition of dioptric power, from one to the next of three different viewing-distance regions. This progressive surface is calculated in accordance with the technique of spline analaysis and is twice continuously differentiable. Such a progressive lens, which is illustratively described for use at computer-screen work stations, has an upper viewing-distance region designed for distant vision, a middle viewing-distance region designed for viewing the computer screen as well as a document arranged alongside the screen, and a lower viewing-distance region designed for near-vision requirements of keyboard operation. Laterally of the near-vision region the power of the lens decreases so that documents lying to the side of the keyboard can also be seen sharply, without moving one's head.
Patent AU-6259299-A (AU)
Title: Lithographic printing plates for use with laser imaging apparatus
Inventor: RORKE THOMAS P
IPC: B41C1/055
Filed: 1999-09-21
Abstract: Provided is a lithographic printing plate comprising a support substrate having disposed thereon an ablative-absorbing layer and, optionally, a durable, ink-accepting surface layer that is not ablative-absorbing. The ablative-absorbing layer may contain a high weight percent of an organic sulfonic acid component. The printing plate may further comprise a hydrophilic polymeric layer interposed between the ablative-absorbing layer and the substrate. The printing plate also comprises a primer layer underlying the ablative-absorbing layer with an adhesion-promoting agent, such as a zirconium compound, present in the primer layer. Also provided are methods of preparing such lithographic printing plates, and methods of preparing imaged lithographic printing plates from such lithographic printing plates by imagewise exposure to a laser and a subsequent cleaning step with water or with a cleaning solution.
Patent AU-6337190-A (AU)
Title: Transmucosal dosage form
Inventor: STANLEY THEODORE H
IPC: A61K31/465
Filed: 1990-08-03
Abstract: Compositions and methods of manufacture for producing a medicament composition capable of absorption through the mucosal tissues of the mouth, pharynx, and esophagus. The present invention relates to such compositions and methods which are useful in administering lipophilic and nonlipophilic drugs in a dose-to-effect manner such that sufficient drug is administered to produce precisely a desired effect. The invention also relates to manufacturing techniques that enable therapeutic agents to be incorporated into nondissolvable drug containment matrixes which are capable of releasing the drug within a patient's mouth. An appliance or holder is preferably attached to the drug containment matrix. Employing the present invention the drug may be introduced into the patient's bloodstream almost as fast as through injection, and much faster than using the oral administration route, while avoiding the negative aspects of both of these methods. The nondissolvable drug containment matrix may include permeation enhancers to increase the drug absorption by the mucosal tissues of the mouth. The matrix composition may also include pH buffering agents to modify the saliva pH thereby increasing the absorption of the drug through the mucosal tissues.
Patent AU-6392600-A (AU)
Title: Method and apparatus for reading a magnetoresistive memory
Inventor: LU YONG
IPC: G11C11/14
Filed: 2000-07-31
Abstract: A method and apparatus for reading a magnetoresistive memory is disclosed wherein the wordline current is turned off during selected sensing operations. This substantially eliminates the noise that is typically injected by the wordline current into the bit structures during the sensing operations, which increases the signal-to-noise ratio on the sense lines. This, in turn, significantly increases the speed of the sensing operations and thus the read access time of the memory. Substantial power savings are also realized.
Patent AU-6507398-A (AU)
Title: Pressure and/or heat applied image transfers
Inventor: MABBOTT ROBERT JOHN
IPC: G11B7/24044
Filed: 1998-03-06
Abstract: There is disclosed a method for preparing a pressure and/or heat applied image transfer sheet and applying an image therefrom to a target surface comprising: applying an image layer to an image area of an image release system on a support, the image release system comprising an image release surface; applying a pressure and/or heat activated adhesive layer over i) the image release system including the image area, and/or ii) at least a portion of the target surface, which adhesive layer adheres more strongly to the image layer than the image layer does to the release surface; contacting, with the application of pressure and/or heat, the target surface and the image transfer sheet such that the dried adhesive layer attaches only in the image area to i) the target surface and/or ii) the image transfer sheet; and peeling off the support together with the adhesive layer except for the image area which is left attached to the target surface.
Patent AU-6618696-A (AU)
Title: P53 protein variants and therapeutical uses thereof
Inventor: CONSEILLER EMMANUEL
IPC: C07K14/82
Filed: 1996-07-17
Abstract: Proteins derived from the product of tumor suppressor gene p53 and having enhanced functions for therapeutical use are disclosed. The proteins advantageously have enhanced tumour suppressor and programmed cell death inducer functions, particularly in proliferative disease contexts where wild-type p53 protein is inactivated. Nucleic acids coding for such molecules, vectors containing same, and therapeutical use thereof, particularly in gene therapy, are also disclosed.
Patent AU-6710500-A (AU)
Title: Trailer brake control system with safety function
Inventor: GARVEY VINCENT ROY
IPC: B60T7/20
Filed: 2000-08-21
Abstract: A tow ball (14) is mounted to a bracket (16) by means of a spacer (20) which incorporates transducers (24) to provide signals indicating forces existing between the towing vehicle and the trailer. A control system is described which is operable to apply braking to the trailer to modify the trailer behavior independently of operation of the vehicle brakes by the operator.
Patent AU-6729487-A (AU)
Title: Method of and apparatus for particulate matter conditioning
Inventor: WYATT GERALD W
IPC: A23L7/10
Filed: 1986-11-14
Abstract: An anaerobic, pasteurizing conditioning system for treating matter such as whole and ground grain, minerals and other ingredients to increase the rate of their conversion and absorption during digestion and thus the nutritional value thereof. The system comprises a direct fired steam generator adapted for producing an effluent stream comprising steam and non-condensible gases, a vapor homogenizer for producing a substantially water-free treatment fluid from the effluent stream, and the treatment fluid containing insufficient oxygen for aerobic bacterial life. The treatment fluid, comprising steam and oxygen deficient non-condensible gases is discharged into the vessel for counter-current flow relative to grain passing therethrough. The operation of the direct fired steam generator is controlled for producing a sufficiently large volume of oxygen deficient gases and steam so that upon passage through the vapor homogenizer a sufficiently large volume of effluent comprising the treatment fluid is provided for purging the grain of other gases flowing therewith and maintaining the deficient oxygen level in the non-condensible gases of the treatment fluid for creating an anaerobic condition. In this manner an improved feedstuff is provided wherein the starch components have first been gelatinized in a heated, anaerobic environment and thereafter fractionated to render the feedstuff more digestible.
Patent AU-6756481-A (AU)
Title: Dectector for detecting air components
Inventor: HEIJENGA B
IPC: G01N31/22
Filed: 1981-02-24
Abstract: The invention provides a detector for detecting air components, e.g. contaminations, and in particular noxious or poisonous contaminations, which device comprises a housing in which an air pervious carrier containing a first reagent is arranged, this detector being adapted to draw air to be tested through said carrier so as to expose this reagent to the air, this reagent being influenced by the components to be detected, which carrier is to be contacted with a second reagent which, together with the first one, can bring about a colour reaction depending on the fact whether the first reagent has been influenced or not. The housing forms, in the operative condition, an integral unit, an air- and liquid-tight container with a rupturable wall and containing a not contaminated liquid contributing to said colour reaction being arranged within said housing, the latter being, furthermore, provided with a yieldable wall portion and a plurality of piercing pins arranged in such a mutual spatial relationship that the container can be pierced by pressing inwards said wall portion, so as to moisten said reagent carrier with the liquid from said container. In particular the second reagent can be contained in a similar second carrier which is normally separated from the first one but is contacted therewith when pressing inwards said wall portion.
Patent AU-7033487-A (AU)
Title: Fluid-flow isolation and control apparatus and method
Inventor: GEORGE EIDSMORE PAUL
IPC: F16K17/24
Filed: 1987-02-04
Abstract: Fluid-flow control apparatus and method are disclosed by which magnetically-positionable elements within a rigid body can be externally manipulated using a controlling source of magnetic flux. The relative attractive forces which bias internal magnetic elements into normally-closed sealing engagement are substantially altered by repositioning the magnetic elements in response to the controlling magnet flux. Complete sealing or isolation against back flow through the valve under conditions of net positive outlet pressure is inhibited by the internal double-acting sealing elements which respond in unified manner to the controlling magnetic flux.
Patent AU-7122900-A (AU)
Title: Cationic liposome delivery of taxanes to angiogenic blood vessels
Inventor: MCDONALD DONALD M
IPC: A61P17/02
Filed: 2000-09-08
Abstract: Angiogenic endothelial cells are selectively targeted with lipid/DNA complexes or cationic liposomes containing a substance which affects the targeted cells by inhibiting or promoting their growth. A site of angiogenesis can be precisely located by administering cationic liposomes containing a detectable label. The complexes may comprise nucleotide constructs which are comprised of promoters which are selectively and exclusively activated in the environment of an angiogenic endothelial cell.
Patent AU-7134196-A (AU)
Title: Process and device for heating a boot internal fitting
Inventor: DALVY OLIVIER
IPC: A47L23/20
Filed: 1996-09-23
Abstract: PCT No. PCT/FR96/01480 Sec. 371 Date Jun. 2, 1997 Sec. 102(e) Date Jun. 2, 1997 PCT Filed Sep. 23, 1996 PCT Pub. No. WO97/13447 PCT Pub. Date Apr. 17, 1997A process and device for heating at least one portion of the internal fitting of a boot, for thermoforming the fitting. The heating of the internal fitting, at a temperature of about 120 DEG -140 DEG  C., is done while the fitting is arranged within the boot. The heated air is emitted from an air distribution element, in which each outlet is positioned relative to the internal fitting at least at a minimum predetermined distance. In a preferred embodiment, the device includes an arrangement for positioning a pair of air distribution elements into respective ones of a pair of boots, including respective seats that receive the vamps of the boots, thereby positioning the boots with their heels extending upwardly, and respective abutments that limit the introduction of the air distribution elements within the boots.
Patent AU-7265294-A (AU)
Title: Imidazo(1,2-a)pyrazine-4-one, preparation thereof and drugs containing same
Inventor: ALOUP JEAN-CLAUDE
IPC: A61P9/08
Filed: 1994-07-11
Abstract: Compounds of formula (I), wherein either R is C=R3, C(R4)R5 or CH-R6, R1 and R2 are hydrogen, halogen, alkyl, alkoxy, amino, acylamino, -NH-CO-NH-Ar, -N=CH-N(alk)alk', nitro, cyano, phenyl, imidazolyl or SO3H, R3 is oxygen, NOH, NO-alk-COOK or CH-R7, R4 is alkyl, -alk-Het or alk-Ar, R5 is alkyl, -alk-Het or -alk-Ar, or C(R4)R5 is cycloalkyl, R6 is hydroxy, alkyl, NR8R9, -alk-OH,-alk-NR8R9, -alk-Ar or -alk-Het, R7 is hydroxy, alkyl, phenyl, -alk-Ar, -alk-Het, NR10R11 or a heterocyclic ring, R8 and R9 are alkyl, or R8 is hydrogen and R9 is hydrogen or alkyl, -COR12, -CSR30 or -SO2R13, R10 and R11 are alkyl or cycloalkyl, R12 is alkyl, cycloalkyl, phenyl, -COO-alk, -CH2-COOX, -CH2-NH2, -NH-alk, -NH-Ar, -NH2 or -NH-Het, R13 is alkyl or phenyl, R30 is -NH-alk, -NH-Ar, -NH2 or -NH-Het; or R is a 2-imidazolylmethyl radical and each of R1 and R2 is a hydrogen atom. The compounds of formula (I) are  alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists, said receptor also being known as the quisqualate receptor. Furthermore, the compounds of formula (I) are non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, and especially NMDA receptor glycine modulation site ligands.
Patent AU-7292994-A (AU)
Title: Rolling mill material handling system
Inventor: SHORE TERENCE MICHAEL
IPC: B21C47/26
Filed: 1994-09-12
Abstract: A rolling mill material handling system includes a cooling bed (20) and an associated laying head and cooling conveyor (38). Hot rolled products may be cut into segments which are shifted laterally onto the cooling bed. Alternatively, the hot rolled products may be directed longitudinally in undivided lengths past the cooling bed to the laying head (32) where they are formed into rings and deposited on the cooling conveyor. <IMAGE>
Patent AU-7327387-A (AU)
Title: Aqueous steroid formulations for nasal administration
Inventor: BENJAMIN ERIC JOEL
IPC: A61K31/58
Filed: 1987-05-21
Abstract: A non-stinging aqueous anti-inflammatory steroid formulation suitable for intranasal administration comprises: an anti-inflammatory steroid in an amount between about 0.01% and about 0.05% (w/v); propylene glycol in an amount between about 2% and about 10% (w/v); PEG 400 in an amount between about 10% and about 25% (w/v); polysorbate 20 in an amount between about 1% and about 4% (w/v); an effective amount of a preservative; an effective amount of a stabilizer; an effective amount of an antioxidant; water; and pH buffering agent sufficient to adjust the pH of the resulting solution to between about 3.5 and about 7.
Patent AU-7441794-A (AU)
Title: Composition for prophylaxis and treatment of myopia
Inventor: SHIGEMITSU TOSHIRO
IPC: A61K31/435
Filed: 1994-10-04
Abstract: A use of a compound of the formula <CHEM> wherein R is an alkyl, R<1> is a hydrogen or an amino and R<2> is a carboxyl or a tetrazole, or a salt thereof for the production of a composition for the prophylaxis and treatment of myopia. The use for the prophylaxis and treatment of myopia of the present invention not only results in relaxing action on the ciliary smooth muscle of rabbit, but also brings about superior effects of prevention and treatment of myopia of the patients on whom Mydrin-M, a conventional preparation for the prophylaxis and treatment of myopia, failed to have effects. In addition, the use does not involve a mydriatic response and is advantageous for the prophylaxis and treatment of myopia.